Genetic variants in one-carbon metabolism genes and breast cancer risk in European American and African American women

International Journal of Cancer

Volumn 137, Issue 3, 2015, Pages 666-677

  Gong, Zhihong ^a   Yao, Song ^a   Zirpoli, Gary ^a   David Cheng, Ting Yuan ^a   Roberts, Michelle ^a,b   Khoury, Thaer ^a   Ciupak, Gregory ^a   Davis, Warren ^a   Pawlish, Karen ^c   Jandorf, Lina ^d   Bovbjerg, Dana H ^e   Bandera, Elisa V ^f,g   Ambrosone, Christine B ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c NEW JERSEY DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^f RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^g RUTGERS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

African American; breast cancer; European American; one carbon metabolism; polymorphisms

Indexed keywords

ESTROGEN RECEPTOR; FOLIC ACID;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BHMT GENE; BREAST CANCER; CANCER RISK; CARBON METABOLISM; CONTROLLED STUDY; DHFR GENE; DIETARY INTAKE; EUROPEAN AMERICAN; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MTHFD1 GENE; MTHFR GENE; MTR GENE; MTRR GENE; ONE CARBON METABOLISM GENE; PRIORITY JOURNAL; RISK ASSESSMENT; SHMT1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SLC19A1 GENE; TYMS GENE; WOMEN'S HEALTH; ALLELE; BLACK PERSON; BREAST NEOPLASMS; CASE CONTROL STUDY; DIET; ENZYMOLOGY; EUROPE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HEALTH SURVEY; METABOLISM; MIDDLE AGED; MULTIFACTORIAL INHERITANCE; ODDS RATIO; RISK; RISK FACTOR; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DIET; EUROPE; FEMALE; FOLIC ACID; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MIDDLE AGED; MULTIFACTORIAL INHERITANCE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION SURVEILLANCE; RECEPTORS, ESTROGEN; RISK; RISK FACTORS; UNITED STATES;

EID: 84929502453     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29434     Document Type: Article

References (55)

1. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30.
2. Amend K, Hicks D, Ambrosone CB,. Breast cancer in African-American women: differences in tumor biology from European-American women. Cancer Res 2006; 66: 8327-30.
3. Brawley OW,. Health disparities in breast cancer. Obstet Gynecol Clin North Am 2013; 40: 513-23.
4. DeSantis C, Ma J, Bryan L, et al., Breast cancer statistics, 2013. CA Cancer J Clin 2014; 64: 52-62.
5. Choi SW, Mason JB,. Folate status: effects on pathways of colorectal carcinogenesis. J Nutr 2002; 132: 2413S-8S.
6. Mason JB,. Biomarkers of nutrient exposure and status in one-carbon (methyl) metabolism. J Nutr 2003; 133: 941S-7S.
7. Bailey LB, Gregory JF, III,. Folate metabolism and requirements. J Nutr 1999; 129: 779-82.
8. Choi SW, Mason JB,. Folate and carcinogenesis: an integrated scheme. J Nutr 2000; 130: 129-32.
9. Lewis SJ, Harbord RM, Harris R, et al., Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk. J Natl Cancer Inst 2006; 98: 1607-22.
10. Larsson SC, Giovannucci E, Wolk A,. Folate and risk of breast cancer: a meta-analysis. J Natl Cancer Inst 2007; 99: 64-76.
11. Shrubsole MJ, Gao YT, Cai Q, et al., MTR and MTRR polymorphisms, dietary intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006; 15: 586-8.
12. Lissowska J, Gaudet MM, Brinton LA, et al., Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. Int J Cancer 2007; 120: 2696-703.
13. Suzuki T, Matsuo K, Hirose K, et al., One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis 2008; 29: 356-62.
14. Maruti SS, Ulrich CM, Jupe ER, et al., MTHFR C677T and postmenopausal breast cancer risk by intakes of one-carbon metabolism nutrients: a nested case-control study. Breast Cancer Res 2009; 11: R91
15. Ma E, Iwasaki M, Junko I, et al., Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in brazilian women. BMC Cancer 2009; 9: 122, 2407-9-122.
16. Kotsopoulos J, Zhang WW, Zhang S, et al., Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer. Breast Cancer Res Treat 2008; 112: 585-93.
17. Weiner AS, Boyarskikh UA, Voronina EN, et al., Polymorphisms in the folate-metabolizing genes MTR, MTRR, and CBS and breast cancer risk. Cancer Epidemiol 2012; 36: e95-e100.
18. Ma E, Iwasaki M, Kobayashi M, et al., Dietary intake of folate, vitamin B2, vitamin B6, vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in japan. Nutr Cancer 2009; 61: 447-56.
19. Ericson U, Sonestedt E, Ivarsson MI, et al., Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the malmo diet and cancer cohort. Cancer. Epidemiol Biomarkers Prev 2009; 18: 1101-10.
20. Ambrosone CB, Ciupak GL, Bandera EV, et al., Conducting molecular epidemiological research in the age of HIPAA: a Multi-institutional Case-control study of breast cancer in African-american and European-American women. J Oncol 2009; 2009: 871250
21. Gong Z, Quan L, Yao S, et al., Innate immunity pathways and breast cancer risk in african american and European-American women in the women's circle of health study (WCHS). PLoS One 2013; 8: e72619
22. Bandera EV, Chandran U, Zirpoli G, et al., Rethinking sources of representative controls for the conduct of case-control studies in minority populations. BMC Med Res Methodol 2013; 13: 2288-13-71
23. Gong Z, Ambrosone CB, McCann SE, et al., Associations of dietary folate, vitamins B6 and B12 and methionine intake with risk of breast cancer among african american and european american women. Int J Cancer 2014; 134: 1422-35.
24. Yu W, Gwinn M, Clyne M, et al., A navigator for human genome epidemiology. Nat Genet 2008; 40: 124-5.
25. Ruiz-Narvaez EA, Rosenberg L, Wise LA, et al., Validation of a small set of ancestral informative markers for control of population admixture in african americans. Am J Epidemiol 2011; 173: 587-92.
26. Pritchard JK, Stephens M, Rosenberg NA, et al., Association mapping in structured populations. Am J Hum Genet 2000; 67: 170-81.
27. Speliotes EK, Willer CJ, Berndt SI, et al., Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010; 42: 937-48.
28. Frosst P, Blom HJ, Milos R, et al., A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-3.
29. van der Put NM, Gabreels F, Stevens EM, et al., A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998; 62: 1044-51.
30. Macis D, Maisonneuve P, Johansson H, et al., Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis. Breast Cancer Res Treat 2007; 106: 263-71.
31. Lissowska J, Gaudet MM, Brinton LA, et al., Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. Int J Cancer 2007; 120: 2696-703.
32. Kotsopoulos J, Zhang WW, Zhang S, et al., Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer. Breast Cancer Res Treat 2008; 112: 585-93.
33. Xu WH, Shrubsole MJ, Xiang YB, et al., Dietary folate intake, MTHFR genetic polymorphisms, and the risk of endometrial cancer among chinese women. Cancer Epidemiol Biomarkers Prev 2007; 16: 281-7.
34. de Aquino SN, Hoshi R, Bagordakis E, et al., MTHFR rs2274976 polymorphism is a risk marker for nonsyndromic cleft lip with or without cleft palate in the brazilian population. Birth Defects Res Clin Mol Teratol 2014; 100: 30-5.
35. Lu M, Wang F, Qiu J,. Methionine synthase A2756G polymorphism and breast cancer risk: a meta-analysis involving 18,953 subjects. Breast Cancer Res Treat 2010; 123: 213-7.
36. Harmon DL, Shields DC, Woodside JV, et al., Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 1999; 17: 298-309.
37. Chen J, Stampfer MJ, Ma J, et al., Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction. Atherosclerosis 2001; 154: 667-72.
38. Bokor S, Meirhaeghe A, Ruiz JR, et al., Group. Common polymorphisms in six genes of the methyl group metabolism pathway and obesity in european adolescents. Int J Pediatr Obes 2011; 6: e336-44.
39. Gaughan DJ, Kluijtmans LA, Barbaux S, et al., The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 2001; 157: 451-6.
40. Hu J, Zhou GW, Wang N, et al., MTRR A66G polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 2010; 124: 779-84.
41. Heil SG, Van der Put NM, Waas ET, et al., Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? Mol Genet Metab 2001; 73: 164-72.
42. Stevens VL, McCullough ML, Pavluck AL, et al., Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence. Cancer Epidemiol Biomarkers Prev 2007; 16: 1140-7.
43. Bentley AR, Raiszadeh F, Stover PJ, et al., No association between cSHMT genotypes and the risk of breast cancer in the nurses' health study. Eur J Clin Nutr 2010; 64: 108-10.
44. Trinh BN, Ong CN, Coetzee GA, et al., Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels. Hum Genet 2002; 111: 299-302.
45. Ashmore JH, Lesko SM, Muscat JE, et al., Association of dietary and supplemental folate intake and polymorphisms in three FOCM pathway genes with colorectal cancer in a population-based case-control study. Genes Chromosomes Cancer 2013; 52: 945-53.
46. Calza S, Hall P, Auer G, et al., Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. Breast Cancer Res 2006; 8: R34
47. Yang XR, Chang-Claude J, Goode EL, et al., Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the breast cancer association consortium studies. J Natl Cancer Inst 2011; 103: 250-63.
48. Ambrosone CB, Young AC, Sucheston LE, et al., Genome-wide methylation patterns provide insight into differences in breast tumor biology between American women of African and European ancestry. Oncotarget 2014; 5: 237-48.
49. Maruti SS, Ulrich CM, Jupe ER, et al., MTHFR C677T and postmenopausal breast cancer risk by intakes of one-carbon metabolism nutrients: a nested case-control study. Breast Cancer Res 2009; 11: R91
50. Chen J, Gammon MD, Chan W, et al., One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res 2005; 65: 1606-14.
51. Ericson UC, Ivarsson MI, Sonestedt E, et al., Increased breast cancer risk at high plasma folate concentrations among women with the MTHFR 677T allele. Am J Clin Nutr 2009; 90: 1380-9.
52. Quan L, Hong CC, Zirpoli G, et al., Variants of estrogen-related genes and breast cancer risk in European and African American women. Endocr Relat Cancer 2014; 21: 853-64.
53. Yao S, Graham K, Shen J, et al., Genetic variants in microRNAs and breast cancer risk in African American and European American women. Breast Cancer Res Treat 2013; 141: 447-59.
54. Zheng Y, Ogundiran TO, Falusi AG, et al., Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers. Carcinogenesis 2013; 34: 1520-8.
55. Zheng W, Cai Q, Signorello LB, et al., Evaluation of 11 breast cancer susceptibility loci in African-American women. Cancer Epidemiol Biomarkers Prev 2009; 18: 2761-4.